Tag: essential tremor

Focused ultrasound earns positive NICE guidance for treatment of essential tremor

INSIGHTEC has announced that The National Institute for Health and Care Excellence (NICE) issued a positive NICE guidance for unilateral MRI-guided focused ultrasound thalamotomy...

The Japanese Ministry of Health, Labour and Welfare approves Exablate Neuro...

The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved InSightec’s Exablate Neuro system for the non-invasive treatment of essential tremor in patients...

Infinity deep brain stimulation system approved in the USA

St Jude Medical has announced the United States Food and Drug Administration approval and first implant of the Infinity deep brain stimulation (DBS) system...

FDA approves first MRI-guided focused ultrasound device to treat essential tremor

The US Food and Drug Administration has approved the first focused ultrasound device to treat essential tremor in patients who have not responded to...

Health Canada approves Insightec’s Exablate Neuro system for the treatment of...

INSIGHTEC has announced that Health Canada has approved its Exablate Neuro system for the treatment of essential tremor. INSIGHTEC’s Exablate Neuro platform is transforming medicine...

Insightec broadcasts the first live Exablate Neuro brain treatment at ISTU...

At the 16th International Symposium on Therapeutic Ultrasound 2016 (ISTU) in Tel Aviv, Israel, INSIGHTEC hosted a first time live broadcast from the MRI room...

InSightec secures US$22 million and appoints Maurice R Ferré as chief...

InSightec has secured a US$22 million as part of its round D investment. This investment has been led by its current shareholders. In addition,...

Exablate Neuro platform approved by Korean Ministry of Food and Drug...

Elbit Imaging, a shareholder in InSightec, has announced that the company’s Exablate Neuro platform has been approved for the treatment of movement, pain and...

Insightec submits pre-market application for FDA approval of Exablate Neuro for...

Insightec has announced that it has submitted a pre-market approval application (PMA) to the US Food and Drug Administration (FDA) for its Exablate Neuro...

Insightec announces launch of Neurosurgery System on 1.5T MRI platform

Insightec has expanded its non-invasive neurosurgery system from 3T to 1.5T magnetic resonance imaging (MRI) systems. This launch expands the potential market for Insightec’s ExAblate...